Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Houston › NPI 1548387418
Clinic

The Methodist Hospital

The Methodist Hospital was paid $4.53M by Medicaid between Aug 2019 and Dec 2024, across 143 billing codes. Its largest line is 99284, emergency room visit (serious) — 56% of everything it billed.

33Billing provider infoTHE METHODIST HOSPITAL
HOUSTON, TX 77030
33aNPI1548387418assigned 03/23/2007
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$4.53M
24GClaims156,781
24DCodes billed143
24AFirst – last monthAug 2019 – Dec 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Texas

Rank by total paid#84 of 320
Median peer was paid$205K
This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201996$2K
20201,771$29K
202143,511$674K
202246,966$1.45M
202339,323$1.86M
2024incomplete25,114$505K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 56% 4,488 4,217 $2.55M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.0% 4,572 4,300 $409K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.8% 1,342 1,286 $218K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.0% 1,204 749 $137K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.5% 1,667 1,582 $112K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 2,887 2,617 $80K
36591 1.6% 1,005 639 $72K
80053 Comprehensive metabolic panel 1.6% 12,582 9,681 $72K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.4% 2,189 2,041 $65K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.3% 362 355 $61K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 688 658 $50K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 12,917 9,729 $43K
131 more codes
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,321 $39K
96367 <1% 429 $36K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,806 $34K
70450 Computed tomography, head or brain; without contrast material <1% 704 $33K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 891 $27K
G0378 Hospital observation service, per hour <1% 390 $25K
83880 <1% 2,234 $24K
71046 Radiologic examination, chest; 2 views <1% 1,381 $24K
86832 <1% 510 $22K
86833 <1% 480 $20K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 650 $19K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 759 $17K
71045 Radiologic examination, chest; single view <1% 1,495 $16K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,808 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,478 $15K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 57 $15K
83735 <1% 5,487 $14K
84703 <1% 2,623 $14K
96361 Intravenous infusion, hydration; each additional hour <1% 96 $12K
84484 <1% 3,322 $12K
84443 Thyroid stimulating hormone (TSH) <1% 1,490 $10K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 114 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 2,308 $9K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 327 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 687 $8K
80048 Basic metabolic panel (calcium, ionized) <1% 3,673 $7K
83605 <1% 2,122 $7K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 68 $7K
86850 <1% 961 $6K
87088 <1% 1,753 $6K
99152 <1% 158 $6K
87497 <1% 827 $5K
96417 <1% 35 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 758 $5K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,400 $5K
80197 <1% 1,849 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,750 $4K
CP008 <1% 98 $4K
85027 <1% 1,639 $4K
84439 <1% 1,051 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 333 $4K
85610 <1% 3,092 $4K
71250 <1% 129 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 924 $4K
85730 <1% 1,994 $3K
87799 <1% 506 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,940 $3K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,102 $3K
76801 <1% 38 $3K
81001 <1% 2,618 $3K
81003 <1% 2,001 $3K
84100 <1% 2,945 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 36 $3K
CP007 <1% 54 $2K
83615 <1% 1,095 $2K
83690 <1% 1,064 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 14 $2K
85007 <1% 1,302 $2K
83970 <1% 459 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 285 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 605 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 1,480 $2K
80061 Lipid panel <1% 1,043 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,157 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 374 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 14 $2K
87070 <1% 486 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 902 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 148 $2K
87077 <1% 771 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 734 $1K
87040 <1% 256 $1K
86901 <1% 1,397 $1K
86900 <1% 1,336 $1K
82550 <1% 489 $1K
86769 <1% 222 $878.59
J1644 Injection, heparin sodium, per 1000 units <1% 475 $865.11
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 38 $845.58
87186 <1% 502 $789.56
87400 <1% 77 $775.48
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 291 $770.03
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 39 $738.84
Q3014 Telehealth originating site facility fee <1% 152 $642.00
82728 <1% 298 $615.23
84702 <1% 61 $613.59
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 22 $437.19
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 797 $423.16
87340 <1% 168 $420.32
82077 <1% 75 $408.82
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,587 $404.79
82150 <1% 278 $401.67
82565 <1% 979 $376.32
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,619 $372.23
A9585 Injection, gadobutrol, 0.1 ml <1% 204 $337.76
86413 <1% 14 $303.76
82607 <1% 127 $299.64
J0690 Injection, cefazolin sodium, 500 mg <1% 726 $286.36
84550 <1% 389 $233.04
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,182 $198.79
83550 <1% 82 $168.41
82570 <1% 698 $164.97
96376 <1% 651 $164.28
36415 Collection of venous blood by venipuncture <1% 5,854 $161.45
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 25 $160.40
80076 <1% 126 $157.24
80179 <1% 14 $141.81
82746 <1% 42 $136.57
80143 <1% 14 $128.04
82805 <1% 17 $124.13
84156 <1% 717 $122.12
86140 <1% 156 $119.84
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 15 $117.90
J3370 Injection, vancomycin hcl, 500 mg <1% 15 $91.32
84132 <1% 292 $88.95
C1769 Guide wire <1% 478 $76.34
88342 <1% 16 $74.96
83540 <1% 48 $69.58
82947 <1% 338 $60.93
81025 <1% 12 $53.72
85014 <1% 524 $48.91
90662 <1% 15 $41.36
0001A <1% 19 $39.94
J2704 Injection, propofol, 10 mg <1% 1,561 $39.83
85651 <1% 80 $37.70
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 367 $19.61
0002A <1% 29 $15.18
84295 <1% 142 $13.48
82784 0% 26 $0.00
G0008 Administration of influenza virus vaccine 0% 31 $0.00
93356 0% 28 $0.00
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOOM, MARC (PRESIDENT/CEO)